Stock data
Zevra Therapeutics, Inc. (ZVRA)
Zevra Therapeutics, Inc. (ZVRA) reported net income of US$83.23M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$62.94M | US$83.23M | — |
| 2024 | — | — | -US$87.00M | -US$105.51M | — |
| 2023 | — | — | -US$49.60M | -US$46.05M | — |
| 2022 | — | — | -US$42.56M | -US$26.77M | — |
| 2021 | — | — | US$7.73M | -US$8.55M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | US$8.75M | — |
| 2026-03-31 | — | US$37.89M | — |
| 2025-12-31 | — | US$12.16M | — |
| 2025-09-30 | — | -US$0.54M | — |
| 2025-06-30 | — | US$74.71M | — |
| 2025-03-31 | — | -US$3.10M | — |
| 2024-12-31 | — | -US$35.74M | — |
| 2024-09-30 | — | -US$33.23M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.